1 Rice DP Hodgson TA Kopstein AN . The economic costs of illness: A replication and update. Health Care Financ Rev1985; 7: 61–80.
2.
2 Kirschstein R . Disease-specific estimates of direct and indirect cost of illness and NIH support – Fiscal year 2000 update.Washington, DC: National Institutes of Health, Department of Health and Human Services; 2000.
3.
3 Goddard M Hauck K Preker A Smith PC . Priority setting in health – a political economy perspective. Health Economics. Policy and Law2006; 1: 79–90.
4.
4 Clabaugh G Ward MM . Cost-of-illness studies in the United States: a systematic review of methodologies used for direct cost. Value Health2008; 11: 13–21.
5.
5 Aaron HJ . The cost of health care administration in the United States and Canada – questionable answers to a questionable question. N Engl J Med2003; 349: 801–803.
6.
6 Margolis J Barron JJ Grochulski WD . Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. J Manag Care Pharm2005; 11: 727–734.
7.
7 Hirsch AT Hartman L Town RJ Virnig BA . National healthcare costs of peripheral arterial disease in the Medicare population. Vasc Med2008; 13: 209–216.
8.
8 Hodgson TA Cohen AJ . Medical care expenditures for selected circulatory diseases: opportunities for reducing national health expenditures. Med Care1999; 37: 994–1012.
9.
9 Migliaccio-Walle K Caro JJ Ishak KJ O’Brien JA . Costs and medical care consequences associated with the diagnosis of peripheral arterial disease. Pharmacoeconomics2005; 23: 733–742.
10.
10 Paris V; Renaud T; Sermet C; . Des comptes de la santé par pathologie: un prototype pour l’année 1998. Dossiers solidarité et santé 2003; 2: 1–8.
11.
11 Asaria P Chisholm D Mathers C Ezzati M Beaglehole R . Chronic disease prevention: health effects and financial costs of strategies to reduce salt and control tobacco use. Lancet2007; 370: 2044–2053.
12.
12 Norgren L Hiatt WR Dormandy JA Nehler MR Harris KA Fowkes FG . Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg2007; 45(suppl S): S5–S67.